FDA Warns Of High Mortality Rate For Medtronic Stent
In a statement posted on its Web site, the FDA wrote that the per-year mortality risk in patients receiving the stent continues to increase for years after the device is implanted.
The mortality rate is also significantly higher for patients who have the stent than for patients who have surgery, the FDA said.
Earlier research had suggested that aneurysm-related mortality was...
To view the full article, register now.